12,302 Xylem Inc. $XYL Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lowered its stake in Xylem Inc. (NYSE:XYL) by 5.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 225,219 shares of the industrial products company’s stock after selling 12,302 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.10% of Xylem worth $22,808,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Dunhill Financial LLC purchased a new position in Xylem in the second quarter valued at about $30,000. Avalon Trust Co purchased a new stake in Xylem during the second quarter worth $35,000. Orion Capital Management LLC purchased a new stake in Xylem during the second quarter worth $35,000. Aventus Investment Advisors Inc. grew its holdings in Xylem by 66.7% in the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock valued at $35,000 after purchasing an additional 120 shares during the last quarter. Finally, Global Assets Advisory LLC acquired a new stake in Xylem in the first quarter valued at $40,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Price Performance

XYL opened at $108.86 on Friday. The company has a 50 day moving average of $106.94 and a two-hundred day moving average of $113.43. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. Xylem Inc. has a 52-week low of $98.58 and a 52-week high of $154.27. The company has a market cap of $25.42 billion, a P/E ratio of 25.92, a P/E/G ratio of 1.76 and a beta of 1.00.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.34 by $0.12. The firm had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%. Xylem’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, analysts expect that Xylem Inc. will post 5.65 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, August 27th were paid a dividend of $0.43 per share. The ex-dividend date was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.6%. Xylem’s dividend payout ratio (DPR) is 40.95%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Barclays dropped their price objective on shares of Xylem from $159.00 to $139.00 and set an “overweight” rating for the company in a research note on Tuesday, October 13th. UBS Group reduced their price objective on Xylem from $138.00 to $112.00 and set a “neutral” rating on the stock in a research report on Monday, October 5th. Citigroup decreased their price objective on Xylem from $172.00 to $148.00 and set a “buy” rating on the stock in a research note on Monday, October 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Xylem in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada cut their target price on shares of Xylem from $164.00 to $135.00 and set an “outperform” rating for the company in a research note on Wednesday, October 14th. Eight research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $140.85.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.